International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Page(s): 47

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, metronidazole, formulation, oral suspension, nitromidazole antibiotic, antiprotozoal agent, amebicide

Related Categories: CANCER AND AIDS, EXCIPIENTS, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 47
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 415
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 416
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 505
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Jul/Aug 2018 Pg. 320
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2018 Pg. 235
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF Friciu Mihaela, Cull Erica, Leclair Grégoire	Sep/Oct 2024 Pg. 408-412
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Nov/Dec 2017 Pg. 494
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Jan/Feb 2018 Pg. 54
Women's Oral Health: Is There a Hormonal Link? Preckshot John	Jan/Feb 2004 Pg. 10-14
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Hydrocortisone 2-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Jul/Aug 2021 Pg. 325
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James	Jan/Feb 2020 Pg. 77-82
Prednisone 5 mg/mL ir Oral Mix Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 497
Temozolomide 10 mg/mL in Oral Mix SF Suspension Allen Loyd V Jr	May/Jun 2021 Pg. 235
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension McElhiney Linda F	Jan/Feb 2021 Pg. 24-28
Nitazoxanide 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2023 Pg. 420
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Return to Top